Circulating N-Linked Glycoprotein Side-Chain Biomarker, Rosuvastatin Therapy, and Incident Cardiovascular Disease: An Analysis From the JUPITER Trial

Journal of the American Heart Association

Volumn 5, Issue 7, 2016, Pages

  Akinkuolie, Akintunde O ^a   Glynn, Robert J ^a   Padmanabhan, Latha ^a   Ridker, Paul M ^a   Mora, Samia ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

cardiovascular disease; epidemiology; glycoprotein; metabolomics; statin intervention

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; HYPOCHOLESTEROLEMIC AGENT; N ACETYLGLUCOSAMINE; ROSUVASTATIN;

AGED; BLOOD; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; RISK;

ACETYLGLUCOSAMINE; AGED; ANTICHOLESTEREMIC AGENTS; BIOMARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK; ROSUVASTATIN CALCIUM;

EID: 85013774720     PISSN: None     EISSN: 20479980     Source Type: Journal    
DOI: 10.1161/JAHA.116.003822     Document Type: Article

References (0)